Beam Therapeuticsの1年間の目標
Beam Therapeuticsの1年間の目標は何ですか。
Beam Therapeutics Inc.の1年間の目標は$89 +270.85%です。
1年間の目標の定義は何ですか。
1年目標は今から1年後の予測株価です。
One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.
NASDAQのセクタHealth Careにおける1年間の目標の企業と比べるBeam Therapeutics
Beam Therapeuticsは何をしますか。
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Beam Therapeuticsと類似の1年間の目標
- Loral Space & Communications Incの1年間の目標は$89 +114.35%です。
- Lonza AGの1年間の目標は$92 +42.20%です。
- Advanced Micro Devicesの1年間の目標は$89 -40.54%です。
- Autolivの1年間の目標は$89 -4.44%です。
- National Aluminiumの1年間の目標は₨89 -50.18%です。
- Shockwave Medicalの1年間の目標は$89 -73.29%です。
- Beam Therapeuticsの1年間の目標は$89 +270.85%です。
- Bank of Indiaの1年間の目標は₨90 -19.19%です。
- Vicorの1年間の目標は$90 +150.28%です。
- Gerresheimer AGの1年間の目標は€90 -14.01%です。
- EHang Ltdの1年間の目標は$13 +8.71%です。
- Dolby Laboratories Incの1年間の目標は$90 +29.04%です。
- Natera Incの1年間の目標は$90 -27.41%です。